Tech Company Financing Transactions
Moderna Funding Round
On 2/3/2018, Moderna raised $500 million in financing from Abu Dhabi Investment Authority, Alexandria Venture Investments and ArrowMark Partners.
Transaction Overview
Company Name
Announced On
2/3/2018
Transaction Type
Venture Equity
Amount
$500,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The funding will help drive the company's continued execution of its rapidly growing pipeline of 19 development candidates -- including 10 programs in clinical trials.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
200 Technology Sq.
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
At Moderna (Nasdaq: MRNA), we are pioneering the development of a new class of drugs made of messenger RNA (mRNA).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Stéphane Bancel
Chief Medical Officer
Tal Zaks
President
Stephen Hoge
VP - General Counsel
Lori Henderson
VP - Manufacturing
Juan Andres
Browse more venture capital transactions:
Prev: 2/3/2018: Lightelligence venture capital transaction
Next: 2/3/2018: Indio Technologies venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to record tech company VC transactions. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs